[1] |
KOLB SA, LAHRTZ F, PAUL R, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid[J]. J Neuroimmunol, 1998, 84(2): 143. doi: 10.1016/S0165-5728(97)00247-6 |
[2] |
COSTA BKD, SATO DK. Viral encephalitis: a practical review on diagnostic approach and treatment[J]. J Pediatr(Rio J), 2020, 96(1): 12. |
[3] |
SUN SZ, WANG L, WU YE, et al. Aciclovir CSF concentration in children with viral encephalitis: is it adequate?[J]. J Antimicrob Chemother, 2018, 73(9): 2582. doi: 10.1093/jac/dky217 |
[4] |
VENKATESAN A, MURPHY OC. Viral encephalitis[J]. Neurol Clin, 2018, 36(4): 705. doi: 10.1016/j.ncl.2018.07.001 |
[5] |
AI J, XIE Z, LIU G, et al. Etiology and prognosis of acute viral encephalitis and meningitis in Chinese children: a multicentre prospective study[J]. BMC Infect Dis, 2017, 17(1): 494. doi: 10.1186/s12879-017-2572-9 |
[6] |
LIND L, ERIKSSON K, GRAHN A. Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus[J]. J Neuroinflammation, 2019, 16(1): 42. doi: 10.1186/s12974-019-1428-1 |
[7] |
TOFT-HANSEN H, BABCOCK AA, MILLWARD JM, et al. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system[J]. J Neuroinflammation, 2007, 4(20): 24. |
[8] |
SULIK A, WOJTKOWSKA M, OLDAK E. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis[J]. Scand J Immunol, 2010, 68(3): 323. |
[9] |
KARAMANOS NK, THEOCHARIS AD, NEILL T, et al. Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases[J]. Matrix Biol, 2019, 75(76): 1. |
[10] |
HANNOCKS MJ, ZHANG X, GERWIEN H, et al. The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes[J]. Matrix Biol, 2019, 75(76): 102. |
[11] |
VAFADARI B, SALAMIAN A, KACZMAREK L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy[J]. J Neurochem, 2016, 139(2): 91. |
[12] |
SONG J, WU C, KORPOS E, et al. Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration[J]. Cell Rep, 2015, 10(7): 1040. |
[13] |
GERWIEN H, HERMANN S, ZHANG X, et al. Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier[J]. Sci Transl Med, 2016, 8(364): 364ra152. |
[14] |
IVAN DC, WALTHERT S, BERVE K, et al. Dwellers and trespassers: mononuclear phagocytes at the borders of the central nervous system[J]. Front Immunol, 2021, 11(5): 609921. |